Contraception
Volume 79, Issue 2 , Pages 111-116 , February 2009

Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial

Received 1 August 2008 ,Revised 2 September 2008 ,Accepted 2 September 2008.

References 

  1. De Fronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
  2. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:375–381
  3. Després JP, Lamarche B, Mauriége P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952–957
  4. De Pirro R, Fusco A, Bertoli A, Greco AV, Lauro R. Insulin receptors during the menstrual cycle in normal women. J Clin Endocrinol Metab. 1978;47:1387–1389
  5. Diamond MP, Simonson DC, De Fronzo RA. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril. 1989;52:204–208
  6. Valdes C, Helkind-Hirsch K. Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab. 1991;72:642–645
  7. Helkind-Hirsch KE, Sherman LD, Malinak R. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure. J Clin Endocrinol Metab. 1993;76:472–475
  8. Lindheim SR, Presser SC, Ditkoff EC, ViJod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril. 1993;60:664–667
  9. ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Hum Reprod. 2001;16:1527–1535
  10. De Pirro R, Forte F, Bertoli A, Greco AV, Lauro R. Changes in insulin receptors during oral contraception. J Clin Endocrinol Metab. 1981;52:29–33
  11. Kasdorf G, Kalkhoff RK. Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents. J Clin Endocrinol Metab. 1988;66:846–852
  12. Skouby SO, Andersen O, Saurberey N. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes. J Clin Endocrinol Metab. 1987;64:519–523
  13. Godsland IF, Walton C, Felton C, Proudler A, Patel LA, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992;74:64–70
  14. Gaspard UJ, Demeyer F, Jaminet CB, Scheen AJ, Lefebvre PJ. Influence of two low dose oral contraceptives containing ethinylestradiol (20 mcg) and desogestrel or gestodene on carbohydrate metabolism during 1 year of use. Gynecol Endocrinol. 1996;10(Suppl 1):179–181
  15. Petersen KR, Christiansen E, Madsbad S, Skouby SO, Andersen LF, Jespersen J. Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives. Contraception. 1999;60:337–344
  16. Cagnacci A, Paoletti AM, Renzi A, et al. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptive containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab. 2003;88:3621–3625
  17. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas. 2004;47:277–283
  18. Cohen JC, Hickman R. Insulin resistance and decreased tolerance in powelifters ingesting anabolic steroids. J Clin Endocrinol Metab. 1987;64:960–963
  19. Holmag A, Larsson BM, Brzezinska M, Bjorntorp P. Effects of short-term testosterone exposure on insulin sensitivity of muscle in female rats. Am J Physiol. 1992;262:E851–E855
  20. Polderman KH, Gooren LJG, Asscheman H, Bakker A, Hein RJ. Induction of insulin resistance by estrogens and androgens. J Clin Endocrinol Metab. 1994;79:265–271
  21. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192:585–594
  22. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. Cellular mechanisms of insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 1992;75:577–583
  23. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800
  24. Dahlgren E, Landin K, Krotkiewski M, Holm G, Janson PO. Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod. 1998;13:2706–2711
  25. Cagnacci A, Paoletti AM, Arangino S, Melis GB, Volpe A. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Reprod. 1999;14:893–897
  26. Moghetti P, Tosi F, Castello R, et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab. 1996;81:952–960
  27. Raudrant D, Rabe T. Progestogens with antiandrogenic properties. Drugs. 2003;63:463–492
  28. Pélissier C, Basdevant A, Conard J, Egloff M, Husson T, Guyenne TT. Contraception progestative par l' acétate de chlormadinone chez des femmes à risqué vasculaire: (étude gynéco-endocrinienne, métabolique et vasculaire). Contracept Fertil Steril. 1987;15:45–54
  29. Schamm G, Steffens D. Contraceptive efficacy and tolerability of chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg (Belara). Drugs Invest. 2002;22:221–231
  30. Welch S, Gebhart SSP, Bergman RN. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab. 1990;71:1508–1518
  31. American Diabetes Association Consensus Development Conference on Insulin Resistance 1998. Diabetes Care. 1998;21:310–314
  32. Cagnacci A, Arangino S, Renzi A, Cagnacci P, Volpe A. Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting. Eur J Endocrinol. 2001;145:281–287
  33. Cagnacci A, Tirelli A, Cannoletta M, Pirillo D, Volpe A. Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis. Contraception. 2005;72:443–446
  34. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB. Effect of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab. 1992;74:1396–1400
  35. Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism. 1983;32:438–446
  36. Wahl P, Walden R, Knopp R, et al. Effects of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1983;308:862–867
  37. Fotherby K. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms estrogen. Contraception. 1992;46:477–488
  38. Song S, Chen JK, Yang PJ, et al. A cross-over study of three oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel. Contraception. 1992;45:523–532
  39. Akerlund M, Almstrom E, Hogstedt S, Nabrink M. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Acta Obstet Gynecol Scand. 1994;73:136–143
  40. Van der Mooren MJ, Klipping C, van Aken B, Helmerhorst E, Spielmann D, Kluft C. A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 1999;4(Suppl 2):27–35
  41. Curram MP, Wagstaff AJ. Ethinylestradiol/chlormadinone acetate. Drugs. 2004;64:751–760

☆ This study received unrestricted funds from the Department of Obstetrics and Gynecology, University of Modena.

☆☆ The present trial was registered with the European Clinical Trial Database (no. 2007-007931-25).

PII: S0010-7824(08)00452-6

doi: 10.1016/j.contraception.2008.09.002

Contraception
Volume 79, Issue 2 , Pages 111-116 , February 2009

Article Tools

* Image Usage & Resolution